Curvebeam AI Ltd
ASX:CVB
Net Margin
Curvebeam AI Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
US |
C
|
Curvebeam AI Ltd
ASX:CVB
|
28.7m AUD |
-246%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
220.2B USD |
32%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
177.7B USD |
29%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
157B USD |
12%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
154.2B USD |
12%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
119.1B USD |
14%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
53.8B EUR |
9%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
53.1B USD |
7%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
46.9B USD |
73%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.6B USD |
23%
|
|
US |
![]() |
Resmed Inc
NYSE:RMD
|
40.4B USD |
26%
|
Curvebeam AI Ltd
Glance View
Curvebeam AI Ltd is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Hatfield, Pennsylvania. The company went IPO on 2023-08-23. Curvebeam AI Ltd is engaged in the research, design, and manufacturing of cone beam computed tomography (CT) imaging systems for the orthopedic specialties. The firm is engaged in providing point-of-care diagnostic cone beam CT imaging solutions with artificial intelligence (AI) and deep learning AI (DLAI). Its product categories include orthopedics and bone health. Its orthopedics products include HiRise, LineUP, pedCAT Premium, pedCAT, InReach, and CubeVue Software. Its bone health products include InReach HR-pQCT, and OSSView. HiRise is a bilateral, weight bearing CT imaging of the entire lower extremities including hips/pelvis, distal upper extremities. LineUP is a bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities. InReach HR-pQCT is a high resolution peripheral quantitative CT (HR-pQCT) imaging system designed for the point-of-care. OssView Bone Fragility software analyzes HR-pQCT images to measure the bone microarchitecture.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Curvebeam AI Ltd's most recent financial statements, the company has Net Margin of -246.1%.